{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,22]],"date-time":"2026-11-22T05:54:38Z","timestamp":1795326878117,"version":"4.10.3"},"reference-count":11,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T00:00:00Z","timestamp":1286409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Rh immune globulin (RhIG) has been used successfully for many years for the antenatal suppression of anti\u2010D in D\u2013 mothers carrying D+ babies to prevent hemolytic disease of the fetus and newborn. Although the mechanism of RhIG\u2010induced immunosuppression remains unknown, a recent report (<jats:bold>TRANSFUSION<\/jats:bold> 2006;46:1316\u201022) has shown that women receiving RhIG produce elevated levels of transforming growth factor (TGF)\u03b2\u20101, a powerful immunosuppressant cytokine. It was suggested that induction of TGF\u03b2\u20101 and immunosuppression may be independent of cognate antigen recognition by RhIG. Herein, we present a description of a mother and baby that supports this hypothesis.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> Red blood cells and serum were analyzed using saline\u2010tube indirect antiglobulin test methods. RhIG (RhoGAM) was administered after each amniocentesis performed at 28, 31, and 36 weeks' gestation.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> A group A, D\u2013(cde), K+, Fy(a\u2212b+), MNs, Jk(a+b+) mother with no detectable anti\u2010D had an anti\u2010Fy<jats:sup>a<\/jats:sup> titer of 4096 before RhIG but only 256 after RhIG. Mother gave birth to a group O, D\u2013(cde), Fy(a+b+) healthy baby boy having a weak\u2010positive direct antiglobulin test with anti\u2010Fy<jats:sup>a<\/jats:sup> eluted from his cells and the titer in the cord serum was 4.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> This case demonstrates the potential immunosuppressive properties of RhIG for down regulation of a possible clinically significant alloantibody, not anti\u2010D, where no D+ antigen is in the circulation of the mother. The case illustrates the potential utility for using RhIG to modulate antibody levels in situations other than for classical suppression of anti\u2010D production. Although the mechanism in this case is unknown, TGF\u03b2\u20101\u2013mediated or antibody\u2010mediated immunosuppression to soluble nonparticulate antigens are possible mechanisms.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2010.02905.x","type":"journal-article","created":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T16:52:25Z","timestamp":1286470345000},"page":"816-819","source":"Crossref","is-referenced-by-count":7,"title":["Unexpected suppression of anti\u2010Fy<sup>a<\/sup> and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin"],"prefix":"10.1111","volume":"51","author":[{"given":"Donald R.","family":"Branch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry L.","family":"Scofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Moulds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane L.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00924_1.x"},{"key":"e_1_2_6_3_2","first-page":"625","volume-title":"Technical manual","author":"Kennedy MS","year":"2008"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(00)01801-9"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(02)00020-2"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5238.1486"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.1964.tb02824.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00898.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40050551.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200522753"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01454.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02479.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2010.02905.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2010.02905.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:40:19Z","timestamp":1697276419000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2010.02905.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,7]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1111\/j.1537-2995.2010.02905.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2010.02905.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,7]]}}}